Core Viewpoint - Organigram Global Inc. has appointed James Yamanaka as the new Chief Executive Officer, effective on or about January 15, 2026, to lead the company in its growth and international expansion efforts [1][4]. Group 1: Leadership Appointment - James Yamanaka, previously Global Head of Strategy at British American Tobacco, brings over 20 years of experience in strategy and general management [2][3]. - Yamanaka's track record includes achieving record market share in Japan and transforming BAT's Northern Europe Area for sustainable growth [3]. - Peter Amirault will serve as executive chair on an interim basis until Yamanaka assumes the CEO role [4]. Group 2: Strategic Vision - Yamanaka expressed enthusiasm for the challenge, highlighting Organigram's position as Canada's number one recreational cannabis company by market share and its potential to become a global leader in the cannabis industry [4]. - The company aims to build an international presence based on high-quality products, trusted brands, and a commitment to innovation [4]. Group 3: Educational Background - James Yamanaka holds a BA in Political Science and Economics from UC San Diego, an M.S. in Foreign Service from Georgetown University, and an MBA from London Business School [4].
Organigram Announces Appointment of Chief Executive Officer